Skip to main content

CAS 2004/O/645 USADA v Montgomery

  • Chapter
  • First Online:
Leading Cases in Sports Law

Part of the book series: ASSER International Sports Law Series ((ASSER))

  • 2217 Accesses

Abstract

The claimant, the United States Anti-Doping Agency (“USADA”), is the independent anti-doping agency for Olympic sports in the United States and is responsible for managing the testing and adjudication process for doping control in that country. The respondent, Tim Montgomery, was an elite and highly successful American track and field athlete. As a sprinter, he had won numerous track and field titles, including World Championship and Olympic gold medals, as well as a world record. In 2004, USADA informed Montgomery that it had received sufficient evidence to indicate that he was a participant in a wide-ranging doping conspiracy implemented by the Californian-based Bay Area Laboratory Cooperative (“BALCO”). USADA sought to ban Montgomery for four years. The legal issue revolved around the fact that USADA had charged Montgomery with the violation of applicable IAAF (athletics’ world governing body) anti-doping rules, notwithstanding that Montgomery had never tested positive in any in-competition or out-of-competition doping test. The matter proceeded directly to a single final hearing before the Court of Arbitration for Sport (“CAS”). A CAS Panel held that doping offences can be proved by a variety of means and thus, for instance, in the absence of any adverse analytical finding, other types of evidence can be substantiated. Among these “alternatives” could be uncontroverted testimony of a wholly credible witness, sufficient to establish that the athlete has admitted to the use of prohibited substances in violation of applicable anti-doping rules. In addition, CAS held that USADA bore the burden of proving, by strong evidence commensurate with the serious claims at issue, that the athlete had committed the doping offences. An important aspect of the CAS award was the discussion on whether a “beyond reasonable doubt” or “comfortable satisfaction” standard of proof should apply in determining doping claims against athletes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    See generally Green 2004 and Beloff 2009.

  2. 2.

    Modahl v British Athletic Federation (No 2) [2001] EWCA Civ 1447; [2002] 1 WLR 1192, 1208.

  3. 3.

    See further Ruijsenaars et al. 2007.

  4. 4.

    Case C-519/04 P David Meca-Medina and Igor Majcen v Commission of the European Communities [2006] ECR I-6991.

  5. 5.

    Weatherill 2006, 657.

  6. 6.

    See, chronologically, Bailey 2007; Szyszczak 2007; Manville 2008; Pijetlovic 2009; and Subiotto 2010.

  7. 7.

    CAS 2004/O/645 USADA v Montgomery.

  8. 8.

    In the early part of this century, Californian-based Bay Area Laboratory Cooperative (“BALCO”) was involved in a conspiracy the purpose of which was the distribution and use of sports doping substances and techniques that were either undetectable or difficult to detect in routine drug testing. The affair prompted numerous public and sport-specific investigations, including the stated proceedings. For its origins, see generally Fainaru-Wada and Williams 2006.

  9. 9.

    Under Article 4.3.1 of the 2009 WADA Code, a substance or method shall be considered for inclusion on the Prohibited List if WADA determines that it meets any two of the following three criteria: 4.3.1.1 Medical or other scientific evidence, pharmacological effect or experience that the substance or method, alone or in combination with other substances or methods, has the potential to enhance or enhances sport performance; 4.3.1.2 Medical or other scientific evidence, pharmacological effect or experience that the Use of the substance or method represents an actual or potential health risk to the Athlete; 4.3.1.3 WADA's determination that the Use of the substance or method violates the spirit of sport described in the Introduction to the Code. Under Article 4.3.2 of the 2009 Code, a substance or method shall also be included on the Prohibited List if WADA determines there is medical or other scientific evidence, pharmacological effect or experience that the substance or method has the potential to mask the Use of other Prohibited Substances or Prohibited Methods.

  10. 10.

    Beloff 2000, 40.

  11. 11.

    De Knop 2000, 20.

  12. 12.

    Walker 2010, 42 and more generally Casini, 2009, 421–446.

  13. 13.

    See generally Oschutz 2002.

  14. 14.

    Under the 2009 WADA Code, the definition of a doping offence under Article 1 is the violation of an anti-doping rule contained in Article 2. They are: the presence of a prohibited substance or its metabolites in an athlete’s sample (Article 2.1); use or attempted use by an athlete of a prohibited substance or a prohibited method (Article 2.2); refusing or failing without compelling justification to sample collection (Article 2.3); violation of applicable requirements regarding athlete availability for out-of-competition testing (Article 2.4); tampering or attempted tampering with any part of doping control (Article 2.5); possession of prohibited substances or prohibited methods (Article 2.6); trafficking or attempted trafficking in any prohibited substance or prohibited method (Article 2.7) and administration or attempted administration to any athlete of any prohibited method or prohibited substance. (Article 2.8).

  15. 15.

    For an early discussion and recognition of strict liability in doping-related sports disputes see CAS 94/129 USA Shooting & Quigley v UIT and Tarasti 2000.

  16. 16.

    CAS 98/211 B v FINA.

  17. 17.

    CAS OG 96/003-004 Korneev and Ghouliev v IOC.

  18. 18.

    CAS 2004/A/651 French v Australian Sports Commission and Cycling Australia.

  19. 19.

    But see CAS 2004/0/607 B v IWF.

  20. 20.

    Arbitral Award AAA no 30 190 00658 04 USADA v Collins. This award was heard before the American Arbitration Association under the auspices of a North American Court of Arbitration for Sport Panel and is available online at: www.usada.org/files/active/arbitration_rulings/AAA%20CAS%20Decision%20-%20Collins.pdf.

  21. 21.

    CAS 2004/0/649 USADA v Gaines.

  22. 22.

    CAS 2004/O/645 USADA v Montgomery, para 3.

  23. 23.

    CAS 2004/O/645 USADA v Montgomery, para 4.

  24. 24.

    CAS 2004/O/645 USADA v Montgomery, para 8.

  25. 25.

    CAS 2004/O/645 USADA v Montgomery, para 5.

  26. 26.

    For the sake of accuracy it should be noted that the CAS Panel had addressed the question of the standard of proof applicable in the present case at a preliminary hearing on 4 March 2005, referred to in the final award as the “Decision on Evidentiary and Procedural Issues”.

  27. 27.

    CAS 2004/O/645 USADA v Montgomery, paras 10–12. USADA requested a doping ban of four years on the basis that IAAF Rule 60 defined the appropriate sanction as being of a minimum of two years. CAS, adopting the sanctions prescribed in the WADA Code, imposed a sanction of two years.

  28. 28.

    See generally Roberts 2007.

  29. 29.

    Soek 2000, 73.

  30. 30.

    See further Trasti 2008; Teitler and Ram 2008 and Marshall and Hale 2008.

  31. 31.

    If there ever was any!

  32. 32.

    Another American sprinter whose record of five World Champion titles and four Olympic medals eclipses that of Montgomery.

  33. 33.

    Associated Press 2009.

  34. 34.

    BBC Sport Online 2005.

References

  • Associated Press (2009) Montgomery obsessed with Greene. http://sports.espn.go.com/oly/news/story?id=4693099. Accessed 31 July 2012

  • Bailey D (2007) Taking the governance of sport out of court. Sports Law Adm Pract (June):5–6

    Google Scholar 

  • BBC Sport Online (2005) Montgomery hit with two-year ban. http://news.bbc.co.uk/sport1/hi/athletics/4521452.stm. Accessed 31 July 2012

  • Beloff M (2000) Drugs, laws and versapaks. In: O’Leary J (ed) Drugs and doping in sport. Cavendish, London

    Google Scholar 

  • Beloff M (2009) Fair play—is there still room for the Corinthian spirit in sport? Int Sports Law Rev 3:34–44

    Google Scholar 

  • Casini L (2009) Global hybrid public-private bodies: the world anti-doping agency. Int Organ Law Rev 6:421–446

    Article  Google Scholar 

  • De Knop P (2000) Globalisation, Americanization and localization in sport. Int Sports Law J 2:20–21

    Google Scholar 

  • Fainaru-Wada M, Williams L (2006) Game of shadows. Gotham, New York

    Google Scholar 

  • Green S (2004) Cheating. Law Philos 23:135–187

    Google Scholar 

  • Manville A (2008) European Court vs sports organisations—who will win the antitrust competition? Int Sports Law J 3/4:19–26

    Google Scholar 

  • Marshall J, Hale A (2008) Will the new WADA code plug all the gaps? Will there be by-catch? Int Sports Law J 1/2:37–42

    Google Scholar 

  • Oschutz F (2002) Harmonisation of anti doping code through arbitration: the case law of the Court of Arbitration for Sport. Marquette Sports Law Rev 12:675–702

    Google Scholar 

  • Pijetlovic K (2009) Paragraph 31 of C-519/04 Meca-Medina reversed. Int Sports Law J 1/2:137–138

    Google Scholar 

  • Roberts H (2007) BALCO and Beyond: The changing landscape in the fight against doping in sport. Sport Law Adm Pract (August):1–7

    Google Scholar 

  • Ruijsenaars P et al (2007) Manifesto: stop the doping inquisition! Int Sports Law J 3/4:84–85

    Google Scholar 

  • Soek J (2000) The fundamental rights of athletes in doping trials. In: O’Leary J (ed) Drugs and doping in sport. Cavendish, London

    Google Scholar 

  • Subiotto R (2010) The adoption and enforcement of anti-doping rules should not be subject to European competition law. Eur Compet Law Rev 31:323–330

    Google Scholar 

  • Szyszczak E (2007) Competition and sport. Eur Law Rev 32:95–110

    Google Scholar 

  • Tarasti L (2000) Legal solutions in international doping cases. SEP Editrice, Milan

    Google Scholar 

  • Tarasti L (2008) Some juridical question marks in the revised world anti-doping code. Int Sports Law J 2/3:17–23

    Google Scholar 

  • Teitler S and Ram H (2008) Analysing the new world anti-doping code: a different perspective. Int Sports Law J 1/2:42–49

    Google Scholar 

  • Walker N (2010) Out of place and out of time: law’s fading co-ordinates. Edinb Law Rev 14:13–46

    Article  Google Scholar 

  • Weatherill S (2006) Anti-doping revisited—the demise of the rule of ‘purely sporting’ interest? Eur Compet Law Rev 27:645–657

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John O’Leary .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 T.M.C. ASSER PRESS, The Hague, The Netherlands, and the author(s)

About this chapter

Cite this chapter

O’Leary, J. (2013). CAS 2004/O/645 USADA v Montgomery . In: Anderson, J. (eds) Leading Cases in Sports Law. ASSER International Sports Law Series. T.M.C. Asser Press, The Hague, The Netherlands. https://doi.org/10.1007/978-90-6704-909-2_12

Download citation

Publish with us

Policies and ethics

Societies and partnerships